Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men (original) (raw)

Abstract

Summary This study for the first time investigates the association of bone mineral density (BMD) with angiographically determined coronary atherosclerosis in men. Our data show that the prevalence of low BMD is very high in men undergoing coronary angiography. However, neither osteopenia nor osteoporosis is associated with an increased prevalence of angiographically determined coronary atherosclerosis. Introduction The association of low BMD with

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (45)

  1. Epstein FH (1996) Cardiovascular disease epidemiology: a journey from the past into the future. Circulation 93:1755-1764
  2. Cooper C, Atkinson EJ, Jacobsen SJ et al (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001-1005
  3. Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures. BMJ 307:1248-1250
  4. Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465-475
  5. Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8:611-617
  6. Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S-17S
  7. Peterson AM, McGhan WF (2005) Pharmacoeconomic impact of non-compliance with statins. Pharmacoeconomics 23:13-25
  8. van Jaarsveld CH, Sanderman R, Ranchor AV et al (2002) Gender-specific changes in quality of life following cardiovascu- lar disease: a prospective study. J Clin Epidemiol 55:1105-1112
  9. Tanko LB, Bagger YZ, Christiansen C (2003) Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73:15-20
  10. Barengolts EI, Berman M, Kukreja SC et al (1998) Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62:209-213
  11. Kiel DP, Kauppila LI, Cupples LA et al (2001) Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 68:271-276
  12. Hak AE, Pols HA, van Hemert AM et al (2000) Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 20:1926-1931
  13. Hofbauer LC, Brueck CC, Shanahan CM et al (2007) Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18:251-259
  14. Doherty TM, Detrano RC (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54:224-230
  15. Schmid K, McSharry WO, Pameijer CH, Binette JP (1980) Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 37:199-210
  16. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402
  17. Bostrom K, Watson KE, Horn S et al (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800-1809
  18. Giachelli CM, Bae N, Almeida M et al (1993) Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696
  19. Dhore CR, Cleutjens JP, Lutgens E et al (2001) Differential expression of bone matrix regulatory proteins in human athero- sclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998-2003
  20. Von der RP, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273-278
  21. Samelson EJ, Kiel DP, Broe KE et al (2004) Metacarpal cortical area and risk of coronary heart disease: the Framingham Study. Am J Epidemiol 159:589-595
  22. Trivedi DP, Khaw KT (2001) Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 12:259-265
  23. Tanko LB, Christiansen C, Cox DA et al (2005) Relationship between osteoporosis and cardiovascular disease in postmeno- pausal women. J Bone Miner Res 20:1912-1920
  24. Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326:310-318
  25. Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326:242-250
  26. Marcovitz PA, Tran HH, Franklin BA et al (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96:1059-1063
  27. Tekin GO, Kekilli E, Yagmur J et al (2008) Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol 131:66-69
  28. Sytkowski PA, D'Agostino RB, Belanger A, Kannel WB (1996) Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 143:338-350
  29. Chobanian AV, Bakris GL, Black HR et al (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572
  30. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
  31. Saely CH, Koch L, Schmid F et al (2006) Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Eur J Clin Invest 36:91-97
  32. Kanis JA, Melton LJ III, Christiansen C et al (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
  33. Drexel H, Aczel S, Marte T et al (2005) Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 28:101-107
  34. Muendlein A, Saely CH, Marte T et al (2008) Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3-482 C>T polymorphisms on their association with coronary artery disease. Atherosclerosis 199:179-186
  35. Marte T, Saely CH, Schmid F et al (2009) Effectiveness of atrial fibrillation as an independent predictor of death and coronary events in patients having coronary angiography. Am J Cardiol 103:36-40
  36. Saely CH, Drexel H, Sourij H et al (2008) Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis 199:317-322
  37. Drexel H, Amann FW, Rentsch K et al (1992) Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 70:436-440
  38. Drexel H, Amann FW, Beran J et al (1994) Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 90:2230-2235
  39. Gluer CC, Eastell R, Reid DM et al (2004) Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res 19:782-793
  40. Haussler B, Gothe H, Gol D et al (2007) Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 18:77-84
  41. Ebeling PR (2008) Clinical practice. Osteoporosis in men. N Engl J Med 358:1474-1482
  42. Hoefle G, Saely CH, Aczel S et al (2005) Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. Int J Obes (Lond) 29:785-791
  43. Saely CH, Koch L, Schmid F et al (2006) Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29:901-907
  44. Varma R, Aronow WS, Basis Y et al (2008) Relation of bone mineral density to frequency of coronary heart disease. Am J Cardiol 101:1103-1104
  45. Saely CH, Vonbank A, Rein P et al (2008) Alanine aminotrans- ferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis. Clin Chim Acta 397:82-86